Should we experience fallout from ongoing GLP-1 lawsuits as they relate to safety, shoring up Management Liability now is a focal point, specifically: Appropriate limits for the size of your company Policy language that extends to appropriate decision makers Elimination of exclusion or limiting clauses for regulatory or derivative claims Consent to settle clauses in favor of the insured, not the insurer As was the case during the opioid epidemic, Federal and State regulators brought mismanagement suits against distributors for allegations such as failure to monitor or detect specific activity, enabling diversion, and disproportionate distribution where large quantities of prescriptions went to areas that differed greatly in population size, indicating a lack of due diligence
GLP-1 receptor agonists are a type of medication that mimic the hormone glucagon-like peptide-1 to help regulate blood sugar, increase insulin secretion, reduce gastric emptying, and increase appetite satiety
It is a blockbuster drug. Ozempic is not available in Nepal yet but as a Least Developed Country (LDC), the country is exempt from patent protection for pharmaceuticals until 1 January 2033, and can manufacture generic medicines without compensating or informing the innovators
Kaplan et al., 2018
Semaglutide slows progression and may halt further decline, but cannot fully reverse scarring that has already formed
In summary, Triquetra GLP-Activate might serve as a supportive tool for those seeking to enhance their control over appetite and metabolism